Tongue Cancer Completed Phase 1 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0029843 (Tongue Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02035527Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTreatment
NCT00049283Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerTreatment